Table 3.

Body-Mass Index (BMI) and Glycated Hemoglobin Level at Follow-up, According to Study Group.^*

Variable	Control	Low-Poverty Voucher			Traditional Voucher
	Prevalence (%)	Intention-to-Treat Estimate (95% CI)†	P Value	Prevalence (%)	Intention-to-Treat Estimate (95% CI)†	P Value	Prevalence (%)
BMI‡
≥30	58.6	−1.19 (−5.41 to 3.02)	0.58	57.5	−0.14 (−6.27 to 5.98)	0.96	58.4
≥35	35.5	−4.61 (−8.54 to −0.69)	0.02	31.1	−5.34 (−11.02 to 0.34)	0.07	30.8
≥40	17.7	−3.38 (−6.39 to −0.36)	0.03	14.4	−3.58 (−7.95 to 0.80)	0.11	15.4
Glycated hemoglobin§
≥6.5%	20.0	−4.31 (−7.82 to −0.80)	0.02	16.3	−0.08 (−5.18 to 5.02)	0.98	20.6

^*The analysis sample consisted of women with a valid BMI measurement (for the BMI analysis) or a valid glycated hemoglobin measurement (for the glycated hemoglobin analysis) in the long-term follow-up data collection. See the Supplementary Appendix for the sample sizes used.

^†Intention-to-treat estimates compare the average outcomes for all participants assigned to an intervention group with the average outcomes for controls, with adjustment for the set of baseline covariates shown in Table 1 and indicators for survey-sample release and random-assignment periods. The effects are calculated with the use of logistic regression and are presented as average marginal effects.

^‡BMI (the weight in kilograms divided by the square of the height in meters) was calculated from measured height and weight for most adults as part of the long-term follow-up data collection. Self-reported values were used for 23 observations in the low-poverty–voucher group, 22 observations in the traditional-voucher group, and 21 observations in the control group.

^§Glycated hemoglobin (HbA_1c) was assayed from dried blood spots collected as part of the long-term follow-up data collection.